CRONNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Cronos Group Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$3.25+0.04 (+1.25%)
Close on Oct 19, 2026
- Market cap
- $1.22B
- P/E (TTM)
- 16.3
- Dividend yield
- –
Dividends
Cronos has not reported a dividend
No dividend per share appears in Cronos's annual filings since fiscal 2016.